orogo
Solicitar cotización

Modified Nucleotides

AMP-PNP lithium salt hydrate

Quick view. A beta,gamma-imido ATP analog supplied as a lithium salt hydrate for ATP analog comparison, nucleotide-binding and enzyme-assay research. CAS 25612-73-1. Catalog target purity: ≥93% HPLC. Availability: Inquiry only — contact OROGO to confirm current availability.

Request a quote Review request checklist

Structure of the AMP-PNP parent nucleotide
Chemical structure
Catalog numberOR-GSS-0001
CAS number25612-73-1
Purity≥93% HPLC
Pack sizeCustom packaging by inquiry

Product profile

Material identity

AMP-PNP lithium salt hydrate is classified as modified nucleotides.

Typical application

AMP-PNP lithium salt hydrate — ATP analog comparison and ATP-dependent enzyme assay research

Handling focus

For AMP-PNP lithium salt hydrate, reported solubility: Water: 50 mg/mL.

Names and search terms

Confirmed or normalized name variants

Useful catalog search terms

Physicochemical data

Salt and HydrateLithium salt hydrate; exact lithium and water stoichiometry varies
ModificationBeta,gamma-imido ATP analog
Parent InChIKeyPVKSNHVPLWYQGJ-KQYNXXCUSA-N
Physical formPowder
Storage temperature-20 C
Free-acid molecular formulaC10H17N6O12P3
Formula basisFree-acid form
Counterion stoichiometryVariable lithium stoichiometry
Hydration stateVariable
Free-acid molecular weight506.20

Release documentation

Lot-specific CoA

The current specification defines the analytical method and acceptance criteria; the released lot result is reported on the CoA.

Analytical package

Additional HPLC, MS or NMR documentation can be agreed during technical review where available.

Additional application examples

Related products

OR-INTE-0013

3'-OMe-GDP Disodium Salt

Modified Nucleotides · CAS: N/A

OR-INTE-0014

3'-OMe-GMP

Modified Nucleotides · CAS: 400806-41-9

OR-INTE-0015

3'-OMe-GMP TEA Salt

Modified Nucleotides · CAS: 860605-85-2

OR-INTE-0021

Im-3'-OMe-GMP

Modified Nucleotides · CAS: 1005791-93-4

OR-INTE-0023

Im-GDP

Modified Nucleotides · CAS: 1199264-75-9

OR-MN-0025

(-)-Emtricitabine Triphosphate Tetrasodium Salt

Modified Nucleotides · CAS: 1188407-46-6

Related OROGO articles

These editorial links discuss the product family, workflow or sourcing context. They are not lot specifications or evidence that every statement applies to this product.

OROGO article

Key Quality Attributes for Modified Nucleotides

Important quality attributes for modified nucleotide sourcing, including purity basis, water content, counterion, storage and enzyme compatibility.

OROGO article

RNA-Based Skincare Is Becoming a Materials Question

PDRN, siRNA, miRNA and tFNA are being discussed together in skincare, but they are different materials with different evidence and formulation questions.

OROGO article

INTerpath-001 Is Positive, but the Phase 3 Effect Size Is Still Missing

INTerpath-001 met RFS and DMFS endpoints, but Phase 3 effect sizes, subgroup results and mature overall survival data remain pending.

Request a quote Review request checklist

Technology platforms

Catalog-derived platform membership for navigating related chemistry and verifiable product sets.

Nucleoside & nucleotide chemistry

View platform scope

mRNA raw-material platform

View platform scope

General selection guidance for evaluating this product family. Confirm the exact product specification and workflow requirements separately.

Choosing modified nucleosides and nucleotides

Review form, hydration, workflow compatibility, analytical basis and storage before use.

Open technical guide